BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 30978435)

  • 1. Relevant updates in systemic mastocytosis.
    Coltoff A; Mascarenhas J
    Leuk Res; 2019 Jun; 81():10-18. PubMed ID: 30978435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic mastocytosis in adults: 2019 update on diagnosis, risk stratification and management.
    Pardanani A
    Am J Hematol; 2019 Mar; 94(3):363-377. PubMed ID: 30536695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic mastocytosis in adults: 2021 Update on diagnosis, risk stratification and management.
    Pardanani A
    Am J Hematol; 2021 Apr; 96(4):508-525. PubMed ID: 33524167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and management of mastocytosis: an emerging challenge in applied hematology.
    Valent P
    Hematology Am Soc Hematol Educ Program; 2015; 2015():98-105. PubMed ID: 26637707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic mastocytosis in adults: 2012 Update on diagnosis, risk stratification, and management.
    Pardanani A
    Am J Hematol; 2012 Apr; 87(4):401-11. PubMed ID: 22410759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Avapritinib for Systemic Mastocytosis.
    Bose P; Verstovsek S
    Expert Rev Hematol; 2021 Aug; 14(8):687-696. PubMed ID: 34289787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic mastocytosis in adults: 2015 update on diagnosis, risk stratification, and management.
    Pardanani A
    Am J Hematol; 2015 Mar; 90(3):250-62. PubMed ID: 25688753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic Mastocytosis: Clinical Update and Future Directions.
    Tremblay D; Carreau N; Kremyanskaya M; Mascarenhas J
    Clin Lymphoma Myeloma Leuk; 2015 Dec; 15(12):728-38. PubMed ID: 26382091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic mastocytosis in adults: 2011 update on diagnosis, risk stratification, and management.
    Pardanani A
    Am J Hematol; 2011 Apr; 86(4):362-71. PubMed ID: 21442641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic mastocytosis in adults: 2017 update on diagnosis, risk stratification and management.
    Pardanani A
    Am J Hematol; 2016 Nov; 91(11):1146-1159. PubMed ID: 27762455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic mastocytosis in adults: 2013 update on diagnosis, risk stratification, and management.
    Pardanani A
    Am J Hematol; 2013 Jul; 88(7):612-24. PubMed ID: 23720340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Insights into the Pathogenesis of Mastocytosis: Emerging Concepts in Diagnosis and Therapy.
    Valent P; Akin C; Sperr WR; Horny HP; Arock M; Metcalfe DD; Galli SJ
    Annu Rev Pathol; 2023 Jan; 18():361-386. PubMed ID: 36270293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDA Approval Summary: Midostaurin for the Treatment of Advanced Systemic Mastocytosis.
    Kasamon YL; Ko CW; Subramaniam S; Ma L; Yang Y; Nie L; Shord S; Przepiorka D; Farrell AT; McKee AE; Pazdur R
    Oncologist; 2018 Dec; 23(12):1511-1519. PubMed ID: 30115735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic Mastocytosis: Advances in Diagnosis and Current Management.
    Pullarkat ST; Wu W; Pullarkat V
    Cancer Treat Res; 2021; 181():167-178. PubMed ID: 34626361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mastocytosis: state of the art.
    Horny HP; Sotlar K; Valent P
    Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precision Medicine in Systemic Mastocytosis.
    Nicolosi M; Patriarca A; Andorno A; Mahmoud AM; Gennari A; Boldorini R; Gaidano G; Crisà E
    Medicina (Kaunas); 2021 Oct; 57(11):. PubMed ID: 34833353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic mastocytosis in adults: 2023 update on diagnosis, risk stratification and management.
    Pardanani A
    Am J Hematol; 2023 Jul; 98(7):1097-1116. PubMed ID: 37309222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic criteria and classification of mastocytosis: a consensus proposal.
    Valent P; Horny HP; Escribano L; Longley BJ; Li CY; Schwartz LB; Marone G; Nuñez R; Akin C; Sotlar K; Sperr WR; Wolff K; Brunning RD; Parwaresch RM; Austen KF; Lennert K; Metcalfe DD; Vardiman JW; Bennett JM
    Leuk Res; 2001 Jul; 25(7):603-25. PubMed ID: 11377686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How I treat patients with indolent and smoldering mastocytosis (rare conditions but difficult to manage).
    Pardanani A
    Blood; 2013 Apr; 121(16):3085-94. PubMed ID: 23426950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on diagnostic approaches and therapeutic strategies in systemic mastocytosis.
    Radia DH; Moonim MT
    Best Pract Res Clin Haematol; 2022 Jun; 35(2):101380. PubMed ID: 36333068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.